Geode Capital Management’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Sell |
380,277
-589,983
| -61% | -$330K | ﹤0.01% | 3853 |
|
|
2025
Q1 | $462K | Sell |
970,260
-21,335
| -2% | -$10.2K | ﹤0.01% | 3570 |
|
|
2024
Q4 | $1M | Buy |
991,595
+23,413
| +2% | +$23.7K | ﹤0.01% | 3377 |
|
|
2024
Q3 | $1.66M | Buy |
968,182
+32,614
| +3% | +$55.8K | ﹤0.01% | 3188 |
|
|
2024
Q2 | $2.39M | Buy |
935,568
+424,977
| +83% | +$1.08M | ﹤0.01% | 3072 |
|
|
2024
Q1 | $2.13M | Buy |
510,591
+42,134
| +9% | +$176K | ﹤0.01% | 3092 |
|
|
2023
Q4 | $1.56M | Buy |
468,457
+3,770
| +0.8% | +$12.5K | ﹤0.01% | 3187 |
|
|
2023
Q3 | $929K | Buy |
464,687
+21,188
| +5% | +$42.4K | ﹤0.01% | 3353 |
|
|
2023
Q2 | $1.4M | Buy |
443,499
+22,322
| +5% | +$70.5K | ﹤0.01% | 3228 |
|
|
2023
Q1 | $1.46M | Buy |
421,177
+11,448
| +3% | +$39.7K | ﹤0.01% | 3164 |
|
|
2022
Q4 | $2.1M | Buy |
409,729
+25,732
| +7% | +$132K | ﹤0.01% | 3019 |
|
|
2022
Q3 | $3.8M | Buy |
383,997
+100,705
| +36% | +$996K | ﹤0.01% | 2814 |
|
|
2022
Q2 | $2.38M | Buy |
283,292
+15,387
| +6% | +$129K | ﹤0.01% | 3054 |
|
|
2022
Q1 | $3.37M | Buy |
267,905
+52,581
| +24% | +$662K | ﹤0.01% | 3000 |
|
|
2021
Q4 | $3.42M | Buy |
215,324
+10,633
| +5% | +$169K | ﹤0.01% | 3102 |
|
|
2021
Q3 | $5.15M | Buy |
204,691
+166,023
| +429% | +$4.18M | ﹤0.01% | 2902 |
|
|
2021
Q2 | $1.13M | Buy |
+38,668
| New | +$1.13M | ﹤0.01% | 3526 |
|